What is the current share price of Nidan Laboratories and Healthcare Limited (NIDAN)?

As of the latest market update, Nidan Laboratories and Healthcare Limited (NIDAN) is trading at ₹13.9. The stock has moved 1.46% up in the recent session.

What is the technical sentiment for NIDAN stock?

Based on our proprietary technical analysis, the current signal for NIDAN is "SELL". This analysis considers over 20+ indicators including RSI, MACD, and moving average crossovers to gauge market momentum.

What is the 52-week high and low for Nidan Laboratories and Healthcare Limited?

Nidan Laboratories and Healthcare Limited has seen a 52-week high of ₹24.9 and a 52-week low of ₹12.75. Comparing the current price to these levels helps investors understand the stock's relative valuation and volatility over the past year.

Which sector does Nidan Laboratories and Healthcare Limited belong to?

Nidan Laboratories and Healthcare Limited operates in the Healthcare sector, specifically within the Healthcare Services industry. Its performance is often influenced by broader trends in the Healthcare segment.

What is the market capitalization of NIDAN?

Nidan Laboratories and Healthcare Limited (NIDAN) has a market capitalization of approximately ₹19 Cr. This classifies it as a small cap stock in the Indian market.

NIDAN

NSE

Nidan Laboratories and Healthcare Limited (SMALL CAP)

Healthcare>Healthcare>Healthcare Services>Healthcare Service Provider

₹13.90

0.20 (1.46%)

As on 12 Jun 2026

Advanced Chart

Price History

Market Cap

The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.

₹19 Cr

SMALL CAP

P/E Ratio

Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.

12.7

Industry

The specific business sector the company operates in. Useful for comparing with similar companies.

Healthcare Service Provider

52-Week Range

The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.

52W Low₹12.75+9.0%

52W High₹24.9-44.2%

Current Price

₹13.90

Circuit Limits (20%)

The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.

Lower Circuit₹11.12

Upper Circuit₹16.68

Reference Price

₹13.90

Investment Checklist

Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹16.45

Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹11.7

Trend: Price below most MAs — downtrend | Bearish MA stack (20<50<200)

10/20 Bearish Cross detected 4 day(s) ago

SuperTrend(10,3): Price below SuperTrend (Industry Standard (Swing/Medium-Term))

Technical Analysis

Analysis from 2026-06-12

Confidence

50%

Trend

BEARISH

Price below most MAs — downtrend | Bearish MA stack (20<50<200)

EMA20

14.1

EMA50

14.51

EMA200

16.98

Price Action

MIXED

NEUTRAL

Higher Highs4

Higher Lows3

Lower Highs3

Lower Lows5

Support & Resistance Levels

Resistance (Above)

₹14.30

₹14.45

₹15.02

₹15.90

₹16.55

Support (Below)

₹13.18

₹13.00

₹12.77

Volume Analysis

TrendDECREASING

Change-63.20%

Unusual VolumeNo

Recent MA Crossovers

10/20 Bearish Cross

4 days ago

SELL

Stop Loss Levels

Fixed Risk

1% Risk₹13.76

3% Risk₹13.48

5% Risk₹13.21

7% Risk (Custom)

₹12.93

Technical Levels

1x ATR (Volatility)₹13.39

2x ATR (Swing)₹12.88

3x ATR (Trend)₹12.37

Immediate Support₹13.18

Financials

Financial data not available

Peer Comparison

Healthcare Service Provider

Peer Comparison

Symbol	Name	Price	Change
LALPATHLAB	Dr. Lal Path Labs Ltd.	₹1,601.50	+0.50%
VIJAYA	Vijaya Diagnostic Centre Limited	₹1,287.20	+0.63%
THYROCARE	Thyrocare Technologies Limited	₹528.90	+1.83%
NEPHROPLUS	Nephrocare Health Services Limited	₹748.15	-0.42%
METROPOLIS	Metropolis Healthcare Limited	₹530.70	+2.03%
KRSNAA	Krsnaa Diagnostics Limited	₹534.30	+0.23%
SURAKSHA	Suraksha Diagnostic Limited	₹268.05	+0.00%
3BBLACKBIO	3B Blackbio Dx Limited	₹1,245.40	-0.69%
HEALTHX	Health X Platform Limited	₹280.90	+0.90%
CHANDAN	Chandan Healthcare Limited	₹226.80	+1.18%

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Corporate Actions

Recent actions

View All

Ex Date	Purpose	Type
20 Sept 2024	ANNUAL GENERAL MEETING	AGM
18 Sept 2023	ANNUAL GENERAL MEETING	AGM
19 Sept 2022	ANNUAL GENERAL MEETING	AGM

Announcements

Latest updates

View All

Date	Description	Link
26 May 2026	Copy of Newspaper Publication
25 May 2026	Change in Management
25 May 2026	Outcome of Board Meeting
29 Apr 2026	Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
28 Apr 2026	Structural Digital Database

Board Meetings

Upcoming and past meetings

View All

Date	Purpose	Links
25 May 2026	Financial Results
25 May 2026	Board Meeting Intimation	XBRL
05 Feb 2026	Board Meeting Intimation	XBRL
05 Feb 2026	Other business matters
10 Nov 2025	Board Meeting Intimation	XBRL

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Latest News

News for NIDAN

View All

Six pharma stocks that should be on your radar today over various news triggers

negative

CNBC TV18 - Markets 19d ago

Six pharma stocks that should be on your radar today over various news triggers

It was a busy weekend for pharma stocks as four of them — Divi's Laboratories, Fortis Healthcare, Torrent Pharma and Narayana Hrudayalaya — reported their quarterly results. Meanwhile, Lupin marked its entry into the Chinese market, while Glenmark Pharma's US arm settled an anti-trust litigation. Here's a look at these names in detail:

DIVISLABFORTISGLENMARKHCGHCG-REHEALTHCARELUPINNHNIDANTRUSTFinancial ServicesHealthcare

Read full story

NEWS

positive

Business Standard - Markets 29d ago

Caplin Steriles receives USFDA approval for Foscarnet Sodium Injection

Caplin Steriles (CSL), a subsidiary company of Caplin Point Laboratories has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Foscarnet Sodium Injection (6000 mg/250 mL Infusion Bag), a generic therapeutic equivalent version of the Reference Listed Drug (RLD) Foscavir Injection from Clinigen Healthcare, (NDA 020068).

CAPLIPOINTHCGHCG-REHEALTHCARENIDANFinancial ServicesHealthcare

Read full story

Unique Picks: 6 stocks held by only one MF scheme in April, falling up to 40% in CY26

positive

ET Markets - Stocks 32d ago

Unique Picks: 6 stocks held by only one MF scheme in April, falling up to 40% in CY26

An analysis of mutual fund portfolios revealed 29 stocks held exclusively by single schemes, with most underperforming in CY26. However, Satin Creditcare Network, Rossell Techsys, and Amanta Healthcare bucked the trend, delivering strong returns. Brooks Laboratories and EFC (I) were among those experiencing significant declines.

ABSLPSEALPHAALPHAETFAMANTAAONEGOLDAONELIQUIDAONENIFTYAONETOTALAUTOBEESAUTOIETFAXISBNKETFAXISBPSETFAXISCETFAXISGOLDAXISHCETFAXISILVERAXISNIFTYAXISTECETFAXISVALUEAXSENSEXBANK10ADDBANKADDBANKBETFBANKETFBANKPSUBBETF0432BBNPNBETFBBNPPGOLDBFSIBROOKSCHEMICALCHOICEGOLDCOMMOIETFDEFENCEDIVIDENDEBANKNIFTYEBBETF0430EBBETF0431EBBETF0433ECAPINSUREEFCILEGOLDELIQUIDELM250ENERGYENIFTYEQUAL200EQUAL50EQUAL50ADDESENSEXESGESILVERFINIETFFLEXIADDFMCGIETFGILT10BETAGILT5BETAGOLD1GOLD360GOLDADDGOLDBETAGOLDBNDGOLDETFGROWWCAPMGROWWCHEMGROWWDEFNCGROWWEVGROWWGOLDGROWWHOSPIGROWWLIQIDGROWWLOVOLGROWWMC150GROWWMETALGROWWMOM50GROWWN200GROWWNETGROWWNIFTYGROWWNXT50GROWWPOWERGROWWPSEGROWWPSUBKGROWWRAILGROWWRLTYGROWWSC250GROWWSLVRGSEC10IETFGSEC10YEARHCGHCG-REHDFCGOLDHDFCGROWTHHDFCLOWVOLHDFCMID150HDFCMOMENTHDFCNEXT50HDFCNIF100HDFCNIFITHDFCPSUBKHDFCPVTBANHDFCQUALHDFCSILVERHDFCSML250HDFCVALUEHEALTHADDHEALTHCAREHEALTHIETFHSBCGOLDICICIB22INFRAIETFINTERNETITADDITBEESITBETAITETFITIETFLICNETFSENLICNMID100LIQGRWBEESLIQUIDLIQUID1LIQUIDPLUSLIQUIDSBILIQUIDSHRILOWVOLMAFANGMAHKTECHMAKEINDIAMANUFGBEESMASPTOP50METALMETALIETFMID150MIDCAPADDMIDCAPBETAMIDCAPETFMIDCAPIETFMIDQ50ADDMNCMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM30IETFMOM50MOMENTUMMOMENTUM30MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTOURMOVALUEMSCIADDMSCIINDIAMULTICAPNEXT30ADDNEXT50NEXT50ADDNEXT50BETANEXT50ETFNEXT50IETFNIDANNIFTY100EWNIFTYADDNIFTYBETFNIFTYETFNIFTYQLITYOILIETFPHARMABEESPSUBANKADDPSUBNKIETFPVTBANKADDQUALITY30ROSSELLINDROSSTECHSATINSBIBPBSBIETFCONSBIETFITSBIETFPBSBIETFQLTYSBILIQETFSBINEQWETFSBINMID150SBISILVERSELECTIPOSENSEXETFSETF10GILTSILVERSILVER1SILVER360SILVERADDSILVERAGSILVERBEESSILVERBETASILVERBNDSILVERIETFSMALL250SMALLADDSNXT30BEESTATAGOLDTATSILVTECHTNIDETFTOP10ADDTOP20TWCGOLDETFUNIONGOLDVAL30IETFVALUECapital GoodsFast Moving Consumer Goods

Read full story

NIDAN

Price History

Investment Checklist

Technical Analysis

Technical Analysis

Trend

Price Action

Support & Resistance Levels

Volume Analysis

Recent MA Crossovers

Stop Loss Levels

Fixed Risk

Technical Levels

Financials

Peer Comparison

Peer Comparison

Corporate Information

Large Deals

Corporate Actions

Announcements

Board Meetings

Corporate Events

Latest News

News for NIDAN

Six pharma stocks that should be on your radar today over various news triggers

Caplin Steriles receives USFDA approval for Foscarnet Sodium Injection

Unique Picks: 6 stocks held by only one MF scheme in April, falling up to 40% in CY26

Frequently Asked Questions

What is the current share price of Nidan Laboratories and Healthcare Limited (NIDAN)?

What is the technical sentiment for NIDAN stock?

What is the 52-week high and low for Nidan Laboratories and Healthcare Limited?

Which sector does Nidan Laboratories and Healthcare Limited belong to?

What is the market capitalization of NIDAN?